NYCEDC, HITLAB announce 4th class of the Digital Health Breakthrough Network

Digital Health Breakthrough Network

New York City Economic Development Corporation (NYCEDC), in partnership with HITLAB, announced the fourth class of the Digital Health Breakthrough Network, an initiative for startups to pilot their products with end-users and strengthen their connection to New York City healthcare and technology sectors.

Perhaps more important is that selected startups in the program will be able to pilot their technologies with clinical partners and patients around the City. The pilots are designed to efficiently provide early-stage startups with initial evidence that will help them improve their products and pitches to investors.

The latest class of promising startups include:

  • Biotia, a DNA sequencing technology and AI software that identifies pathogens and drug resistance markers to prevent hospital-acquired infections;
  • Soundmind, a voice assistant tool to support the care of older adults;
  • OpticSurg, an augmented reality software tool to support surgical procedures; and
  • KnowNOW, a telehealth platform that provides testing and treatment for sexually transmitted diseases.

“The Digital Health Breakthrough Network strives to solve medical challenges by supporting innovative startups that are improving healthcare through the application of new technologies,” NYCEDC President and CEO James Patchett said in a statement. “NYCEDC is very proud of this remarkable class of startups, and we look forward to the program’s continued success.”

Since 2016, the Digital Health Breakthrough Network has completed pilot studies on behalf of twelve startups supported by the program. The technologies have been tested in partnership with clinics and medical centers including Housing Works, The New Jewish Home, and the Reeds Center.

As a result of the program, eight companies from previous cohorts have created 41 new jobs, raised $2.5 million in funds, served 119 patients in health care facilities and engaged with 88 clinicians in the product testing process.